TY - JOUR
T1 - Approaches for the integration of big data in translational medicine
T2 - single-cell and computational methods
AU - Amirmahani, Farzane
AU - Ebrahimi, Nasim
AU - Molaei, Fatemeh
AU - Faghihkhorasani, Ferdos
AU - Jamshidi Goharrizi, Kiarash
AU - Mirtaghi, Seyede Masoumeh
AU - Borjian-Boroujeni, Marziyeh
AU - Hamblin, Michael R.
N1 - Publisher Copyright:
© 2021 New York Academy of Sciences.
PY - 2021
Y1 - 2021
N2 - Translational medicine describes a bench-to-bedside approach that eventually converts findings from basic scientific studies into real-world clinical research. It encompasses new treatments, advanced equipment, medical procedures, preventive and diagnostic approaches creating a bridge between basic studies and clinical research. Despite considerable investment in basic science, improvements in technology, and increased knowledge of the biology of human disease, translation of laboratory findings into substantial therapeutic progress has been slower than expected, and the return on investment has been limited in terms of clinical efficacy. In this review, we provide a fresh perspective on some experimental and computational approaches for translational medicine. We cover the analysis, visualization, and modeling of high-dimensional data, with a focus on single-cell technologies, sequence, and structure analysis. Current challenges, limitations, and future directions, with examples from cancer and fibrotic disease, will be discussed.
AB - Translational medicine describes a bench-to-bedside approach that eventually converts findings from basic scientific studies into real-world clinical research. It encompasses new treatments, advanced equipment, medical procedures, preventive and diagnostic approaches creating a bridge between basic studies and clinical research. Despite considerable investment in basic science, improvements in technology, and increased knowledge of the biology of human disease, translation of laboratory findings into substantial therapeutic progress has been slower than expected, and the return on investment has been limited in terms of clinical efficacy. In this review, we provide a fresh perspective on some experimental and computational approaches for translational medicine. We cover the analysis, visualization, and modeling of high-dimensional data, with a focus on single-cell technologies, sequence, and structure analysis. Current challenges, limitations, and future directions, with examples from cancer and fibrotic disease, will be discussed.
KW - cancer
KW - computational approach
KW - science
KW - therapeutic progress
KW - translational medicine
UR - http://www.scopus.com/inward/record.url?scp=85102990132&partnerID=8YFLogxK
U2 - 10.1111/nyas.14544
DO - 10.1111/nyas.14544
M3 - Review article
C2 - 33410160
AN - SCOPUS:85102990132
SN - 0077-8923
VL - 1493
SP - 3
EP - 28
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
IS - 1
ER -